The global Continuous Renal Replacement Therapy (CRRT) market size is projected to reach USD 2.1 billion by 2028 from USD 1.4 billion in 2023, at a CAGR of 8.1% during the forecast period.
The growing incidence of acute renal disease, the rising availability of advanced CRRT disposables and replacement fluids, and increasing of government initiatives for carrying out awareness about CRRT are expected to attribute to the growth of the market in the coming years
To know about the assumptions considered for the study download the pdf brochure
The key players which are operating in the continuous renal replacement therapy market are Fresenius Medical Care AG & Co. KGaA (Germany), Baxter International Inc. (US), and B. Braun Melsungen AG (Germany). The players in the global continuous renal replacement therapy market have employed various strategies to expand their global footprints and increase their market shares
Fresenius Medical Care AG & Co. KGaA (Germany)
Fresenius Medical Care AG & Co. KGaA is one of the major global players of products and services which are used for patients with renal diseases.Fresenius Medical Care also provides a range of other goods and services, such as dialysis equipment, supplies, and home dialysis therapy programs. Additionally, the business runs a network of dialysis centers around the world. The company is leading the field of CRRT therapeutic innovation .The business is always creating new and enhanced CRRT goods and services. The company’s Healthcare Product division includes two primary segments, Dialysis Products and Non- Dialysis Products. The CRRT products are offered through the Dialysis Products segment.The company has a wide geographic range across the globe.
Baxter International Inc. (US)
Baxter is one of the key players in the healthcare industry which engages in development, manufacturing, and marketing of products for the treatment of patients with Kidney diseases, infectious diseases, , , and cancer. The products manufactured by the company are innovative and technologically advanced. Baxter operates majorly through two segments—Renal and Hospital Products. The company offers a diverse product portfolio of dialysis products which includes products for PD, in-center HD, home HD, and CRRT, as well as additional dialysis services. Additionally, Baxter provides a range of CRRT consumables, including filters, tubing sets, and replacement products. Additionally, the business offers assistance and training to doctors who utilize its CRRT systems. Leading suppliers of CRRT goods and services include Baxter. The business is dedicated to giving its clients the greatest products and services available and assisting them in getting the best results for their patients.Baxter has a wide geographic presence which includes more than100 countries.
B. Braun Melsungen AG
Braun Melsungen AG offers a diverse range of CRRT products which, includes machines, hemofilters, bloodline systems, vascular access products, and dialysate solutions. In order to treat patients with acute kidney injury (AKI) and other renal illnesses, the company provides a number of CRRT systems, including as the Prismaflex and Prismax systems. These systems are utilized in hospitals and clinics all over the world The company has a strong geographical network .The company has manufacturing facilities in Germany, Brazil, China, France, India, Malaysia, Poland, Switzerland, Spain, Hungary, the US, and Vietnam, among other countries.
Continuous Renal Replacement Therapy Market by Product (Hemofilter, Bloodline, Machines, Dialysates), Modality (SCUF, CVVH, CVVHD, CVVHDF), Age (Adult, Pediatric), Enduser (Hospitals, Ambulatory), and Region - Global Forecast to 2028
Mr. Aashish Mehra
630 Dundee Road
Northbrook, IL 60062
USA : 1-888-600-6441
This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.SEND ME A FREE SAMPLE